These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26349913)

  • 1. Apoptotic effect of tannic acid on fatty acid synthase over-expressed human breast cancer cells.
    Nie F; Liang Y; Jiang B; Li X; Xun H; He W; Lau HT; Ma X
    Tumour Biol; 2016 Feb; 37(2):2137-43. PubMed ID: 26349913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells.
    Li P; Tian W; Ma X
    Mol Cancer; 2014 Jun; 13():138. PubMed ID: 24894151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells.
    Ho TS; Ho YP; Wong WY; Chi-Ming Chiu L; Wong YS; Eng-Choon Ooi V
    Biomed Pharmacother; 2007 Oct; 61(9):578-87. PubMed ID: 17904792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.
    Menendez JA; Colomer R; Lupu R
    Oncol Rep; 2004 Aug; 12(2):411-22. PubMed ID: 15254710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2
    Jordan LG; Booth BW
    J Biomed Mater Res A; 2018 Jan; 106(1):26-32. PubMed ID: 28877394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of desoxyrhaponticin and rhaponticin, two natural stilbene glycosides from the Tibetan nutritional food Rheum tanguticum Maxim. ex Balf., on fatty acid synthase and human breast cancer cells.
    Li P; Tian W; Wang X; Ma X
    Food Funct; 2014 Feb; 5(2):251-6. PubMed ID: 24362821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin inhibits intracellular fatty acid synthase and induces apoptosis in human breast cancer MDA-MB-231 cells.
    Fan H; Liang Y; Jiang B; Li X; Xun H; Sun J; He W; Lau HT; Ma X
    Oncol Rep; 2016 May; 35(5):2651-6. PubMed ID: 26985864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
    Menendez JA; Vellon L; Lupu R
    Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
    Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
    Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.
    Corominas-Faja B; Vellon L; Cuyàs E; Buxó M; Martin-Castillo B; Serra D; García J; Lupu R; Menendez JA
    Histol Histopathol; 2017 Jul; 32(7):687-698. PubMed ID: 27714708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitisin B as a novel fatty acid synthase inhibitor induces human breast cancer cells apoptosis.
    Wang X; Jiang B; Lv H; Liang Y; Ma X
    Am J Transl Res; 2019; 11(8):5096-5104. PubMed ID: 31497225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
    Zhou W; Simpson PJ; McFadden JM; Townsend CA; Medghalchi SM; Vadlamudi A; Pinn ML; Ronnett GV; Kuhajda FP
    Cancer Res; 2003 Nov; 63(21):7330-7. PubMed ID: 14612531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of fatty acid synthase (FAS) and apoptosis in estrogen-receptor positive and negative breast cancer cells by conjugated linoleic acids.
    Song HJ; Sneddon AA; Heys SD; Wahle KW
    Prostaglandins Leukot Essent Fatty Acids; 2012 Dec; 87(6):197-203. PubMed ID: 23142364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts.
    Pizer ES; Thupari J; Han WF; Pinn ML; Chrest FJ; Frehywot GL; Townsend CA; Kuhajda FP
    Cancer Res; 2000 Jan; 60(2):213-8. PubMed ID: 10667561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH accumulation is responsible for apoptosis in breast cancer cells induced by fatty acid synthase inhibition.
    Cui Y; Xing P; Wang Y; Liu M; Qiu L; Ying G; Li B
    Oncotarget; 2017 May; 8(20):32576-32585. PubMed ID: 28427229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.